IRMO uses minimally invasive, non-surgical solutions to for treating orthopedic problems from tennis elbow to degenerative arthritis. The center boasts using a hybrid of traditional orthopedics combined with technological innovations for regenerative medicine.
IRMO believes its work with mesenchymal stem cells could result in advances in tissue re-engineering to re-grow and repair damaged tissue.
More Articles on Orthopedic Leaders:
Stem Cell Treatment & Minimally Invasive Spine Stabilization in Outpatient Surgery Centers: Q&A With Laser Spine Institute on New Procedures
9 Expectations for ASC Orthopedics in 2012-13
First 50 Robotic Knee Surgeries at San Francisco Surgery Center: Q&A With Orthopedic Surgeon Dr. Kevin Stone and Surgery Center Administrator Jeff Wong
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
